Company news

Merit Medical Systems, Inc. news in 2025

Merit Medical Systems, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Merit Medical to Participate at the J.P. Morgan Healthcare Conference

December 22, 2025

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

November 12, 2025

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

November 4, 2025

Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

November 2, 2025

Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance

October 29, 2025

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology

October 14, 2025

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

October 2, 2025

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology

September 30, 2025

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis

September 11, 2025

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

August 17, 2025

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

August 6, 2025

Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance

July 29, 2025

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

July 6, 2025

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 2, 2025

Merit Medical Acquires Biolife Delaware, L.L.C.

May 19, 2025

Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis

May 5, 2025

Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

May 4, 2025

Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance

April 23, 2025

Merit Medical Launches the Ventrax™ Delivery System

April 8, 2025

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

April 6, 2025

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

March 24, 2025

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

March 17, 2025

First Patient Enrolled in Merit Medical’s PREEMIE Study

March 9, 2025

Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance

February 24, 2025

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

January 12, 2025

Calls in 2025

Decks in 2025